Multiple Sclerosis

Revised McDonald criteria allow earlier and more precise MS diagnosis

Presented By

Prof. Xavier Montalban, Vall d'Hebron University Hospital, Spain

Conference

ECTRIMS 2024

Type

News article

25 September 2024 11:03

Blood markers predict MS progression

Presented By

Dr Ahmed Abdelhak, University of California San Francisco, USA

Conference

ECTRIMS 2024

Type

News article

25 September 2024 11:01

High depression genetic burden associated with MS disease activity

Presented By

Dr Kaarina Kowalec, University of Manitoba, Canada

Conference

ECTRIMS 2024

Type

News article

25 September 2024 11:00

More comorbidity is associated with worse clinical outcomes in MS

Presented By

Dr Amber Salter, University of Texas Southwestern, USA

Conference

ECTRIMS 2024

Type

News article

25 September 2024 10:58

First-line moderate-efficacy DMTs show similar efficacy

Presented By

Dr Clara López-Caneda, Hospital Alvaro Cunqueiro, Spain

Conference

ECTRIMS 2024

Type

News article

25 September 2024 10:57

Tolebrutinib slows disability in non-relapsing secondary progressive MS

Presented By

Prof. Robert Fox, Cleveland Clinic, OH, USA

Trial

Phase 3, HERCULES

Conference

ECTRIMS 2024

Type

News article

24 September 2024 10:45

Risk factors and importance of persistent PIRA

Conference

ECTRIMS 2024

Type

News article

24 September 2024 10:43

Frexalimab shows favourable safety and efficacy in OLE

Presented By

Prof. Gavin Giovannoni, Queen Mary University of London, UK

Trial

Phase 2

Conference

ECTRIMS 2024

Type

News article

24 September 2024 10:40

Transfer of ocrelizumab into breastmilk is negligible

Presented By

Dr Riley Bove, University of California San Francisco, CA, USA

Trial

Phase 4, SOPRANINO

Conference

ECTRIMS 2024

Type

News article

24 September 2024 10:36

Ineffective response to EBV in MS not seen in similar diseases

Presented By

Dr Tilman Schneider-Hohendorf, University of Münster, Germany

Conference

ECTRIMS 2024

Type

News article

24 September 2024 10:33

Encouraging real-world results of AHSCT to treat aggressive MS

Presented By

Prof. Paolo Muraro, London Bridge Hospital, UK

Conference

ECTRIMS 2024

Type

News article

23 September 2024 11:42

B-cell-tailored dosing of ocrelizumab shows good results

Trial

Phase 4, BLOOMS

Conference

ECTRIMS 2024

Type

News article

23 September 2024 11:40

Tolebrutinib slows disability worsening in relapsing MS

Presented By

Dr Jiwon Oh, St. Michael's Hospital, Canada

Trial

Phase 3, GEMINI 1, GEMINI 2

Conference

ECTRIMS 2024

Type

News article

23 September 2024 11:38

High-dose simvastatin does not slow disability progression in SPMS

Presented By

Prof. Jeremy Chataway, University College London, UK

Trial

Phase 3, MS-STAT2

Conference

ECTRIMS 2024

Type

News article

23 September 2024 11:36

Gut microbiota modulates inflammation and cortical damage

Presented By

Dr Federico Montini, Brigham and Women's Hospital, Boston, MA, USA

Conference

ECTRIMS 2024

Type

News article

23 September 2024 11:35